Abstract
K+ channels are key regulators of cellular excitability. Mutations that activate K+ channels can lower cellular excitability, whereas those that inhibit K+ channels may increase excitability. We show that the Caenorhabditis elegans egl-2 gene encodes an eag K+ channel and that a gain- of-function mutation in egl-2 blocks excitation in neurons and muscles by causing the channel to open at inappropriately negative voltages. Tricyclic antidepressants reverse egl-2(gf) mutant phenotypes, suggesting that EGL-2 is a tricyclic target. We verified this by showing that EGL-2 currents are inhibited by imipramine. Similar inhibition is observed with the mouse homolog MEAG, suggesting that inhibition of EAG-like channels may mediate some clinical side effects of this class of antidepressants.
Original language | English |
---|---|
Pages (from-to) | 9831-9840 |
Number of pages | 10 |
Journal | Journal of Neuroscience |
Volume | 19 |
Issue number | 22 |
DOIs | |
State | Published - Nov 15 1999 |
Keywords
- Antidepressant
- Caenorhabditis elegans
- Imipramine
- K channel
- Tricyclic
- eag
- egl-2